Publication | Closed Access

Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study

UrologyGenitourinary CancerMedicineProstatic DiseaseOncologyRadiation OncologyEndocrine-related CancerVersus Docetaxel